Silence Therapeutics Plc (SLN) ownership: insiders 8% · institutions 17% · index and ETF funds 0% (13F 2026-06-30). Insider activity, 90 days: 17 sales, 0 open-market buys. SEC EDGAR first-party data.
| Holder | Shares | Market Value | % Outstanding | Reported |
|---|---|---|---|---|
| Siren, L.L.C. | 3311438.00 | $36.36M | 2.3% | 2026-06-30 |
| TCG Crossover Management, LLC | 3033560.00 | $33.31M | 2.1% | 2026-06-30 |
| Redmile Group, LLC | 2164777.00 | $23.77M | 1.5% | 2026-06-30 |
| Janus Henderson | 1087228.00 | $19.80M | 0.8% | 2026-06-30 |
| Nantahala Capital Management, LLC | 1346731.00 | $14.79M | 1.0% | 2026-06-30 |
| Citadel | 1329625.00 | $14.60M | 0.9% | 2026-06-30 |
| Nextech Invest Ltd. | 952400.00 | $10.46M | 0.7% | 2026-06-30 |
| Millennium Management | 909279.00 | $9.98M | 0.6% | 2026-06-30 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-10 | |
| Sell | null | 2026-08-10 | |
| Sell | null | 2026-08-10 | |
| Sell | null | 2026-08-10 | |
| Sell | null | 2026-08-10 | |
| Sell | null | 2026-08-10 | |
| Sell | null | 2026-08-10 | |
| Sell | null | 2026-08-10 |
Back to SLN overview · SLN earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.